Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, August 12, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2019 published in 'The Economic Times' an English Daily and 'Maharashtra Times' a Regional Daily, on August 02, 2019. Kindly take the same on record.
05-08-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2019

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2019. Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2019 and shall remain closed till 48 hours after the announcement of the Financial Results i.e. up to Wednesday, August 14, 2019. Kindly acknowledge and take on record the same.
01-08-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates. This is for your information and record.
25-07-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Intimation Regarding Proposed Transfer Of Shares Of The Company Pursuant To The SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 Dated 6Th November, 2018.

 Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated 6th November, 2018, we would like to inform you that the Company has received through its Registrar & Share Transfer Agent (RTA) M/s. Universal Capital Securities Private Limited, requests for transfer of physical shares. In view of same, the Company has published newspaper advertisement in 'The Free Press Journal' an English Daily and 'Navshkati' a Regional Daily on July 16, 2019 giving notice of proposed transfer of shares. If within 30 days of the said notice, no objection is received in this regard then the Company shall effect the proposed transfer of shares. A copy of the said advertisement is enclosed herewith. You are requested to the take the above on your records.
16-07-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Shareholding for the Period Ended June 30, 2019

 Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
15-07-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2019. Kindly take the same on record.
13-07-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ms. Aditi BhattDesignation :- Company Secretary and Compliance Officer
13-07-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for transmission of shares cum issuance of duplicate share certificates. This is for your information and record.
06-07-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 In accordance with reference to the circulars issued by BSE vide Circular no. LIST/COMP/01/2019-20 and NSE vide Circular no. NSE/CML/2019/11 dated April 2, 2019 and in complying with the aforesaid circulars and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and in terms of Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, we wish to inform you that, the Trading window for dealing in securities/shares of the Company will remain closed for all the Designated Persons and their immediate relatives of the Company with effect from Monday, July 01, 2019 until 48 hours after the announcement of the un-audited financial results of the Company for the quarter ending June 30, 2019. Accordingly, all Designated Persons of the Company have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
29-06-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed disclosure of Related Party Transactions on the basis on consolidated financial statements for the year ended March 31, 2019.
18-06-2019
Next Page
Close

Let's Open Free Demat Account